Clinical Trial Update: TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tinzaparin as thromboprophylaxis in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Thromboembolism

Drugs mentioned

• tinzaparin (tinzaparin)

Snippet

Sponsor: Galician Research Group on Digestive Tumors | Conditions: Colorectal Cancer Metastatic, Thromboembolism | Phase 3 | Status: COMPLETED